Skip to main content
NIH funding notice RFA-DK-19-505

Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Knowledge Portal (UM1 Clinical Trial Not Allowed)

Closed on December 3, 2019.

Posted
September 27, 2019
Close date
December 3, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 renewal
First-year cost
$4,099,350
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BROAD INSTITUTE, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZDK1 GRB-N (M3))1
1 award under RFA-DK-19-505 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020The next iteration of the AMP-T2D Knowledge Portal2UM1DK105554-06Boehnke, Michael LBurtt, Noel PFlannick, JasonBROAD INSTITUTE, INC., MAFirst-year cost $4,099,350Study section ZDK1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-DK-19-505: Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Knowledge Portal (UM1 Clinical Trial Not Allowed) | ScienceDex